Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling

被引:5
|
作者
Stencel, Jason [1 ]
Alai, Hamid R. [1 ,2 ]
Dhore-patil, Aneesh [1 ]
Urina-Jassir, Daniela [1 ]
Le Jemtel, Thierry H. [1 ]
机构
[1] Tulane Univ, Heart & Vasc Inst, John W Deming Dept Med, Sect Cardiol,Sch Med, New Orleans, LA 70112 USA
[2] Southeast Louisiana VA Healthcare Syst SLVHCS, New Orleans, LA 70119 USA
关键词
obesity; HFpEF; metabolic bariatric surgery; left ventricular mass; epicardial adipose tissue; BODY-MASS INDEX; EPICARDIAL ADIPOSE-TISSUE; CORONARY MICROVASCULAR DYSFUNCTION; ARTERY RISK DEVELOPMENT; BARIATRIC SURGERY; DIASTOLIC DYSFUNCTION; EXERCISE INTOLERANCE; WEIGHT-LOSS; ENDOTHELIAL DYSFUNCTION; OLDER PATIENTS;
D O I
10.3390/jcm12093341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Owing to the overwhelming obesity epidemic, preserved ejection fraction heart failure commonly ensues in patients with severe obesity and the obese phenotype of preserved ejection fraction heart failure is now commonplace in clinical practice. Severe obesity and preserved ejection fraction heart failure share congruent cardiovascular, immune, and renal derangements that make it difficult to ascertain whether the obese phenotype of preserved ejection fraction heart failure is the convergence of two highly prevalent conditions or severe obesity enables the development and progression of the syndrome of preserved ejection fraction heart failure. Nevertheless, the obese phenotype of preserved ejection fraction heart failure provides a unique opportunity to assess whether sustained and sizeable loss of excess body weight via metabolic bariatric surgery reverses the concentric left ventricular remodeling that patients with preserved ejection fraction heart failure commonly display.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Left Ventricular Stiffening as Therapeutic Target for Heart Failure With Preserved Ejection Fraction
    Sakata, Yasushi
    Ohtani, Tomohito
    Takeda, Yasuharu
    Yamamoto, Kazuhiro
    Mano, Toshiaki
    CIRCULATION JOURNAL, 2013, 77 (04) : 886 - 892
  • [32] Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction
    Wong, Lee Lee
    Armugam, Arunmozhiarasi
    Sepramaniam, Sugunavathi
    Karolina, Dwi Setyowati
    Lim, Kai Ying
    Lim, Jia Yuen
    Chong, Jenny P. C.
    Ng, Jessica Y. X.
    Chen, Yei-Tsung
    Chan, Michelle M. Y.
    Chen, Zhaojin
    Yeo, Poh Shuan D.
    Ng, Tze P.
    Ling, Lieng H.
    Sim, David
    Leong, Kui Toh G.
    Ong, Hean Y.
    Jaufeerally, Fazlur
    Wong, Raymond
    Chai, Ping
    Low, Adrian F.
    Lam, Carolyn S. P.
    Jeyaseelan, Kandiah
    Richards, Arthur Mark
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (04) : 393 - 404
  • [33] The Impact of Left Ventricular Hypertrophy as a Risk of Heart Failure with Preserved Ejection Fraction
    Yamamoto, Kazuhiro
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S128 - S128
  • [34] Biomarkers in heart failure with preserved versus reduced left ventricular ejection fraction
    Van Wijk, S.
    Van Empel, V.
    Maeder, M. T.
    Muzzarelli, S.
    Jeker, U.
    Dieterle, T.
    Handschin, R.
    Kiencke, S.
    Pfisterer, M. E.
    Brunner-La Rocca, H. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 92 - 92
  • [35] Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
    Filippatos, Gerasimos
    Butler, Javed
    Farmakis, Dimitrios
    Zannad, Faiez
    Ofstad, Anne Pernille
    Ferreira, Joao Pedro
    Green, Jennifer B.
    Rosenstock, Julio
    Schnaidt, Sven
    Brueckmann, Martina
    Pocock, Stuart J.
    Packer, Milton
    Anker, Stefan D.
    CIRCULATION, 2022, 146 (09) : 676 - 686
  • [36] Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction
    Marechaux, Sylvestre
    Six-Carpentier, Marie M.
    Bouabdallaoui, Nadia
    Montaigne, David
    Bauchart, Jean Jacques
    Mouquet, Frederic
    Auffray, Jean Luc
    Le Tourneau, Thierry
    Asseman, Philippe
    LeJemtel, Thierry H.
    Ennezat, Pierre Vladimir
    HEART AND VESSELS, 2011, 26 (03) : 313 - 320
  • [37] Biological markers for the diagnosis of heart failure with preserved left ventricular ejection fraction
    Bazaeva, E. Ekaterina
    Boytsov, S. A.
    Myasnikov, R. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 129 - 129
  • [38] Abnormalities of left ventricular systolic function in heart failure with preserved ejection fraction
    Kraigher-Krainer, E.
    Shah, A. M.
    Zile, M. R.
    Pieske, B. M.
    Voors, A. A.
    Lefkowitz, M. P.
    Bransford, T. L.
    Packer, M.
    McMurray, J. J.
    Solomon, S. D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S30 - S30
  • [39] Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction
    Sylvestre Maréchaux
    Marie M. Six-Carpentier
    Nadia Bouabdallaoui
    David Montaigne
    Jean Jacques Bauchart
    Frédéric Mouquet
    Jean Luc Auffray
    Thierry Le Tourneau
    Philippe Asseman
    Thierry H. LeJemtel
    Pierre Vladimir Ennezat
    Heart and Vessels, 2011, 26 : 313 - 320
  • [40] Clinical Predictors of Preserved Left Ventricular Ejection Fraction in Decompensated Heart Failure
    Goldraich, Livia
    Clausell, Nadine
    Biolo, Andreia
    Beck-da-Silva, Luis
    Rohde, Luis Eduardo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (03) : 385 - 393